Athanasios Bakalakos

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Cardiac Resynchronization Therapy

Left Ventricular

Acute Myocardial Infarction

Top Venues

Heart (British Cardiac Society)

Circulation. Genomic and precision medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliott
Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society) 110 (12) (2024)
Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliott
Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society) (2024)
Douglas E Cannie, Kush Patel, Alexandros Protonotarios, Imogen Heenan, Athanasios Bakalakos, Petros Syrris, Leon Menezes, Perry M Elliott
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block. Open heart 11 (1) (2024)
Douglas E Cannie, Kush Patel, Alexandros Protonotarios, Imogen Heenan, Athanasios Bakalakos, Petros Syrris, Leon Menezes, Perry M Elliott
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block. Open heart 11 (1) (2024)
Douglas E Cannie, Kush Patel, Alexandros Protonotarios, Imogen Heenan, Athanasios Bakalakos, Petros Syrris, Leon Menezes, Perry M Elliott
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block. Open heart 11 (1) (2024)
Douglas E Cannie, Kush Patel, Alexandros Protonotarios, Imogen Heenan, Athanasios Bakalakos, Petros Syrris, Leon Menezes, Perry M Elliott
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block. Open heart 11 (1) (2024)
Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliott
Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society) 110 (12) (2024)
Douglas E Cannie, Kush Patel, Alexandros Protonotarios, Imogen Heenan, Athanasios Bakalakos, Petros Syrris, Leon Menezes, Perry M Elliott
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block. Open heart 11 (1) (2024)
Emanuele Monda, Gaetano Diana, Francesco Mariani, Marta Rubino, Athanasios Bakalakos, Ales Linhart, Dominique Paul Germain, Maurizio Scarpa, Elena Biagini, Maurizio Pieroni, Perry Mark Elliott, Giuseppe Limongelli
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies. Circulation. Genomic and precision medicine (2023)